Treatment Details – 14.8 months
|Patients: This Phase I study involved 27 patients with malignant pleural mesothelioma. None of these patients had received prior chemotherapy.|
Treatment: The treatment consisted of two chemotherapy drugs, pemetrexed and carboplatin (paraplatin).
Toxicity: Toxicities included hematologic (grade 3-4), and grade 1-3 nausea, vomiting, diarrhea, and stomatitis.
Results: Median survival time was 451 days (14.8 months).
Correspondence: Andy Hughes, MD, PhD